AgoneX Biopharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch AgoneX Biopharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous AGX-201 for Migraine Prophylaxis (NCT02021474) | AgoneX Biopharmaceuticals, Inc. | 2022-10-01 |
Track AgoneX Biopharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.